Aurobindo Pharma stock: Results call set for November 5, 2026

Company: Aurobindo Pharma Limited
ISIN: INE406A01037
Announcement date: October 26, 2026
Next investor call: November 5, 2026, 8:30 a.m. IST
Reporting period: Second quarter and first half ended September 30, 2026

Published on 11/01/2026 at 01:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Aurobindo Pharma stock has a results call scheduled for November 5. The company will discuss unaudited second-quarter and first-half figures.

Results call sets next catalyst

Aurobindo Pharma will discuss its September-quarter and first-half results with analysts and investors.
The company plans to make its earnings presentation available after the results announcement.

Aurobindo, INE406A01037, Illustration mit AI erstellt.

Aurobindo Pharma will hold an analyst and investor call on Thursday, November 5, 2026, to discuss unaudited results for the second quarter and first half ended September 30. The company announced the schedule on October 26 in an Aurobindo Pharma investor notice.

Scheduled earnings discussion

The call is set for 8:30 a.m. India Standard Time. The company said the earnings presentation will be available on its website after the results announcement, giving investors a further reference point for the September-quarter update.

The upcoming disclosure will provide the next scheduled checkpoint for assessing revenue, profitability and operating trends after the first half of the 2026-27 financial year. Investors will also be able to compare management's commentary with market expectations for the period.